Skip to content
Clinic Scenarios: Improving Awareness of PNH in Primary Care Settings – An
In The Clinic
Activity Evaluation (ID: i850a)
*
1.
How many years have you been in practice?
(Required.)
≥21
11-20
1-10
<1
*
2.
How many patients with PNH do you manage per month?
(Required.)
1 to 5
6 to 10
11 to 20
I am not directly involved in patient care
*
3.
Please select the option that best describes your practice setting:
(Required.)
Academic medical center
Community medical center
VA, DOD, or other government
Managed care
Research
Pharmaceutical industry
*
4.
After participating in this activity, how confident are you in the management of patients with PNH in your practice?
(Required.)
Very confident
Confident
Neutral
Little confidence
No confidence
*
5.
How familiar are you with the complement cascade and complement inhibitors?
(Required.)
Very familiar
Somewhat familiar
Not familiar at all
*
6.
Have you ever managed a patient with PNH?
(Required.)
Yes, I currently do
Yes, one or two in the past
No, I never have
*
7.
How committed are you to making changes in your practice based on your participation in this activity?
(Required.)
Very committed
Committed
Neutral
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason
*
8.
Which of the following best describes the impact of this activity on your performance?
(Required.)
I gained new strategies/skills/information I can apply to my area of practice
I need more information before I can change my practice
My practice is already consistent with the information presented
This activity will not change my practice
*
9.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Become better acquainted with signs and symptoms that indicate PNH
Consider DAT/Coombs testing in patients with low hemoglobin and hemoglobinuria
Become more familiar with the complement cascade and complement inhibitors that prevent hemolysis
Differentiate between C3 and C5 inhibitors for PNH
Carefully monitor patients on complement inhibitors for evidence of meningococcal infection
Ensure prophylactic vaccinations of patients with PNH
Coordinate monitoring of any patients with PNH with their hematologists
*
10.
What barriers do you see to making changes in your practice? Please select all that apply.
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement, or legal issues
Conflicting guidelines or evidence
Patient compliance and/or patient resource barriers
Other (please specify)
*
11.
Please rate your level of agreement by checking the appropriate rating.
After participating in today’s activity, I am now better able to:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Identify symptoms, disease manifestations, and assessment criteria that indicate the need for PNH testing and referral to a hematology expert
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Describe the pathogenesis of PNH, the complement cascade, and complement inhibitors
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Devise a strategy for monitoring patients with PNH who are being treated with complement inhibitors
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
12.
Please rate your level of agreement by checking the appropriate rating.
Carlos M. de Castro III, MD effectively:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Presented the material
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided commercial bias
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
13.
The content presented:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Enhanced my current knowledge base
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Addressed my most pressing questions
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Promoted improvements or quality in health care
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Was scientifically rigorous and evidence based
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided commercial bias or influence
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
14.
If you indicated that you perceived commercial bias or influence, please describe:
15.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for PNH:
16.
As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?